81 related articles for article (PubMed ID: 19421541)
1. A theoretical study on the hydrolysis process of two Keppler-type antitumor complexes [TzH][trans-RuCl4(Tz)2] and [2-NH2TzH][trans-RuCl4(2-NH2Tz)2].
Chen JC; Chen LM; Liao SY; Zheng KC; Ji LN
Phys Chem Chem Phys; 2009 May; 11(18):3401-10. PubMed ID: 19421541
[TBL] [Abstract][Full Text] [Related]
2. The hydrolysis process of the anticancer complex [ImH][trans-RuCl4(Im)2]: a theoretical study.
Chen J; Chen L; Liao S; Zheng K; Ji L
Dalton Trans; 2007 Aug; (32):3507-15. PubMed ID: 17680040
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, structural characterization, solution chemistry, and preliminary biological studies of the ruthenium(III) complexes [TzH][trans-RuCl4(Tz)2] and [TzH][trans-RuCl4(DMSO)(Tz)].(DMSO), the thiazole analogues of antitumor ICR and NAMI-A.
Mura P; Camalli M; Messori L; Piccioli F; Zanello P; Corsini M
Inorg Chem; 2004 Jun; 43(13):3863-70. PubMed ID: 15206867
[TBL] [Abstract][Full Text] [Related]
4. A theoretical study on the hydrolysis process of the antimetastatic ruthenium(III) complex NAMI-A.
Chen J; Chen L; Liao S; Zheng K; Ji L
J Phys Chem B; 2007 Jul; 111(27):7862-9. PubMed ID: 17579393
[TBL] [Abstract][Full Text] [Related]
5. The hydrolysis mechanism of the anticancer ruthenium drugs NAMI-A and ICR investigated by DFT-PCM calculations.
Vargiu AV; Robertazzi A; Magistrato A; Ruggerone P; Carloni P
J Phys Chem B; 2008 Apr; 112(14):4401-9. PubMed ID: 18348562
[TBL] [Abstract][Full Text] [Related]
6. Contrasting chemistry of cis- and trans-platinum(II) diamine anticancer compounds: hydrolysis studies of picoline complexes.
McGowan G; Parsons S; Sadler PJ
Inorg Chem; 2005 Oct; 44(21):7459-67. PubMed ID: 16212372
[TBL] [Abstract][Full Text] [Related]
7. Hydrolysis of the tumor-inhibiting ruthenium(III) complexes HIm trans-[RuCl4(im)2] and HInd trans-[RuCl4(ind)2] investigated by means of HPCE and HPLC-MS.
Küng A; Pieper T; Wissiack R; Rosenberg E; Keppler BK
J Biol Inorg Chem; 2001 Mar; 6(3):292-9. PubMed ID: 11315565
[TBL] [Abstract][Full Text] [Related]
8. Pre-catalyst resting states: a kinetic, thermodynamic and quantum mechanical analyses of [PdCl2(2-oxazoline)2] complexes.
Gossage RA; Jenkins HA; Jones ND; Jones RC; Yates BF
Dalton Trans; 2008 Jun; (23):3115-22. PubMed ID: 18521454
[TBL] [Abstract][Full Text] [Related]
9. The second-generation anticancer drug Nedaplatin: a theoretical investigation on the hydrolysis mechanism.
Alberto ME; Lucas MF; Pavelka M; Russo N
J Phys Chem B; 2009 Oct; 113(43):14473-9. PubMed ID: 19778071
[TBL] [Abstract][Full Text] [Related]
10. Theoretical study of the acid-promoted hydrolysis of oxazolin-5-one: a microhydration model.
Zeng Y; Xue Y; Yan G
J Phys Chem B; 2008 Aug; 112(34):10659-67. PubMed ID: 18680333
[TBL] [Abstract][Full Text] [Related]
11. Hydration of cyclohexylamines: CPCM calculation of hydration Gibbs energy of the conformers.
Jesus AJ; Tomé LI; Eusébio ME; Rosado MT; Redinha JS
J Phys Chem A; 2007 May; 111(17):3432-7. PubMed ID: 17417830
[TBL] [Abstract][Full Text] [Related]
12. Theoretical analysis on the transition state of the anticancer drug trans-[PtCl2(isopropylamine)2] and its cis isomer binding to DNA purine bases.
Zhou L
J Phys Chem B; 2009 Feb; 113(7):2110-27. PubMed ID: 19173577
[TBL] [Abstract][Full Text] [Related]
13. Influence of amine ligands on the aquation and cytotoxicity of trans-diamine platinum(II) anticancer complexes.
Cubo L; Quiroga AG; Zhang J; Thomas DS; Carnero A; Navarro-Ranninger C; Berners-Price SJ
Dalton Trans; 2009 May; (18):3457-66. PubMed ID: 19381408
[TBL] [Abstract][Full Text] [Related]
14. Neutral and acidic hydrolysis reactions of the third generation anticancer drug oxaliplatin.
Lucas MF; Pavelka M; Alberto ME; Russo N
J Phys Chem B; 2009 Jan; 113(3):831-8. PubMed ID: 19143575
[TBL] [Abstract][Full Text] [Related]
15. Exploiting soft and hard X-ray absorption spectroscopy to characterize metallodrug/protein interactions: the binding of [trans-RuCl4(Im)(dimethylsulfoxide)][ImH] (Im = imidazole) to bovine serum albumin.
Ascone I; Messori L; Casini A; Gabbiani C; Balerna A; Dell'Unto F; Castellano AC
Inorg Chem; 2008 Oct; 47(19):8629-34. PubMed ID: 18722420
[TBL] [Abstract][Full Text] [Related]
16. Computational Electrochemistry of Ruthenium Anticancer Agents. Unprecedented Benchmarking of Implicit Solvation Methods.
Chiorescu I; Deubel DV; Arion VB; Keppler BK
J Chem Theory Comput; 2008 Mar; 4(3):499-506. PubMed ID: 26620790
[TBL] [Abstract][Full Text] [Related]
17. A DFT study on the mechanism of a novel, regioselective, intramolecular N-pi rearrangement of cis and trans-eta1-N-Cp*Rh-hydroxytamoxifen complexes to their eta6 derivatives; potential breast cancer pharmaceuticals, and fluorescent probes.
Efremenko I; Top S; Martin JM; Fish RH
Dalton Trans; 2009 Jun; (22):4334-43. PubMed ID: 19662311
[TBL] [Abstract][Full Text] [Related]
18. Theoretical study on the trans-cis isomerization and initial decomposition of energetic azofurazan and azoxyfurazan.
Wang L; Tuo X; Yi C; Zou H; Xu J; Xu W
J Mol Graph Model; 2009 Sep; 28(2):81-7. PubMed ID: 19427249
[TBL] [Abstract][Full Text] [Related]
19. On the hydrolysis mechanism of the second-generation anticancer drug carboplatin.
Pavelka M; Lucas MF; Russo N
Chemistry; 2007; 13(36):10108-16. PubMed ID: 17896336
[TBL] [Abstract][Full Text] [Related]
20. Theoretical study of the C(3P) + trans-C4H8 reaction.
Li Y; Liu HL; Huang XR; Wang DQ; Sun CC
J Phys Chem A; 2009 Jun; 113(24):6800-11. PubMed ID: 19514788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
